KR19990043995A - 발암억제를 위한 카르보스티릴 유도체의 용도 - Google Patents

발암억제를 위한 카르보스티릴 유도체의 용도 Download PDF

Info

Publication number
KR19990043995A
KR19990043995A KR1019980701227A KR19980701227A KR19990043995A KR 19990043995 A KR19990043995 A KR 19990043995A KR 1019980701227 A KR1019980701227 A KR 1019980701227A KR 19980701227 A KR19980701227 A KR 19980701227A KR 19990043995 A KR19990043995 A KR 19990043995A
Authority
KR
South Korea
Prior art keywords
carbostyryl
formula
carbon
active ingredient
salt
Prior art date
Application number
KR1019980701227A
Other languages
English (en)
Korean (ko)
Inventor
도시오 다까하시
데쓰로 야마네
Original Assignee
오오쓰까 아끼히꼬
오오쓰까 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오오쓰까 아끼히꼬, 오오쓰까 세이야꾸 가부시끼가이샤 filed Critical 오오쓰까 아끼히꼬
Publication of KR19990043995A publication Critical patent/KR19990043995A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019980701227A 1995-09-06 1996-08-20 발암억제를 위한 카르보스티릴 유도체의 용도 KR19990043995A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7228889A JPH0971532A (ja) 1995-09-06 1995-09-06 発癌抑制剤
JP95-228889 1995-09-06

Publications (1)

Publication Number Publication Date
KR19990043995A true KR19990043995A (ko) 1999-06-25

Family

ID=16883451

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019980701227A KR19990043995A (ko) 1995-09-06 1996-08-20 발암억제를 위한 카르보스티릴 유도체의 용도

Country Status (7)

Country Link
EP (1) EP0848610A1 (zh)
JP (1) JPH0971532A (zh)
KR (1) KR19990043995A (zh)
CN (1) CN1195987A (zh)
AU (1) AU705751B2 (zh)
CA (1) CA2228898A1 (zh)
WO (1) WO1997009045A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4394686B2 (ja) 2003-07-30 2010-01-06 大塚製薬株式会社 唾液分泌促進用医薬組成物およびその使用
US8303868B2 (en) 2009-01-26 2012-11-06 Shin-Etsu Chemical Co., Ltd. Wet granulation tableting method using aqueous dispersion of low-substituted hydroxypropyl cellulose
CN103476753B (zh) 2011-02-25 2015-12-09 诺弗米克斯有限公司 新的瑞巴派特复合物和共晶体
KR101395984B1 (ko) * 2011-10-21 2014-05-16 가톨릭대학교 산학협력단 레바미피드를 유효성분으로 포함하는 비만의 예방 또는 치료용 조성물
DE102012218773A1 (de) * 2012-10-15 2014-04-17 Continental Automotive Gmbh Verfahren und Einrichtung zur Messung eines Stroms durch einen Schalter
EP3797773A1 (en) * 2019-09-03 2021-03-31 Square Power Ltd Rebamipide for use in prophylaxis and treatment of cancer
CN110974968B (zh) * 2019-12-11 2021-03-26 中山万远新药研发有限公司 含有喹诺酮类化合物的组合物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6010031B2 (ja) * 1983-10-31 1985-03-14 大塚製薬株式会社 カルボスチリル誘導体の製造法
ES2138971T3 (es) * 1991-07-03 2000-02-01 Otsuka Pharma Co Ltd Regulador de la apoptosis.
TW227558B (zh) * 1992-05-14 1994-08-01 Otsuka Pharma Co Ltd
JP2872546B2 (ja) * 1992-11-26 1999-03-17 大塚製薬株式会社 腸粘膜障害保護剤

Also Published As

Publication number Publication date
JPH0971532A (ja) 1997-03-18
EP0848610A1 (en) 1998-06-24
AU705751B2 (en) 1999-06-03
CA2228898A1 (en) 1997-03-13
CN1195987A (zh) 1998-10-14
AU6710096A (en) 1997-03-27
WO1997009045A1 (en) 1997-03-13

Similar Documents

Publication Publication Date Title
PL183144B1 (pl) Preparat farmaceutyczny do doustnego podawania inhibitora pompy protonowej
JPS63101321A (ja) イブプロフエン含有医薬組成物
AU652951B2 (en) Codeine salt of a substituted carboxylic acid, processes for the preparation thereof, its use and pharmaceutical compositions
JP2001527036A (ja) 治療剤
JPH0148247B2 (zh)
KR19990043995A (ko) 발암억제를 위한 카르보스티릴 유도체의 용도
JPH03275640A (ja) 新規抗潰瘍物質
TW415843B (en) Anti-cancer pharmaceutical compositions comprising a diaminotrifluoromethylpyridine derivatives or the pharmaceutically acceptable salts thereof
CA1307739C (en) Anti-inflammatory compositions
CH667592A5 (de) 9,10-dihydrogenierte ergotalkaloide enthaltende pharmazeutische zusammensetzungen.
JP3333545B2 (ja) ジリスロマイシンを含有する医薬製剤
KR0175345B1 (ko) 장점막 장애 예방 및 치료제
KR100192534B1 (ko) 소마토스타틴 분비증가제와 분비저하 억제제
JP2665357B2 (ja) 心不全治療用医薬組成物
JPH0374329A (ja) 胃炎治療剤
AU740749B2 (en) Method of treatment
WO1994014444A1 (en) Psoriasis remedy
JPS6026770B2 (ja) 消化管潰瘍治療剤
GB2234898A (en) Oral pharmaceutical dosage form improving bioavailability
JP2702284B2 (ja) ソマトスタチン増加用またはソマトスタチン低下抑制用薬剤
EP0182569A2 (en) Use of 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4H-pyrido[1,2-a]pyrimidine-3-carboxamide for the prevention and treatment of gastrointestinal damages
JPH02142743A (ja) テルペン化合物及び該化合物を含有する抗消化性潰瘍剤
JPS63295579A (ja) 骨粗鬆症治療剤
JPS5936617A (ja) 抗潰瘍医薬組成物及びその製造方法
WO1998021194A1 (en) Novel biphenyl dicarboxylic acid derivatives and process for preparing them

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid